← Leaderboards
David Takeda
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Enhancers”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$383,951,488
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
- Lawrence Corey · Fred Hutchinson Cancer Center$313,017,695
- Chanza Baytop · Westat, Inc.$271,217,917
- Everette D Joseph · Howard University$249,567,890
Research focus
EnhancersEpigenetic ProcessDisease ProgressionTherapeutic TargetMalignant Neoplasm Of ProstateTumorInsightAdvanced Prostate CancerResistanceCastration Resistant Prostate CancerRegulatory ElementAndrogen ReceptorGenomeMalignant NeoplasmsTranscription FactorAntiandrogen TherapyBiological ModelsAutomobile DrivingGenerationsChromatin ImmunoprecipitationNormal CellGenetic TranscriptionFunctional GenomicsGenomic Approach
Grant awards (12)
Identification of epigenetic drivers of advanced prostate cancer$733,909
ZIA · FY2025 · CA · contact PI
Mechanism of epigenetic activation during disease progression$733,909
ZIA · FY2025 · CA · contact PI
Mechanism of epigenetic activation during disease progression$838,796
ZIA · FY2024 · CA · contact PI
Identification of epigenetic drivers of advanced prostate cancer$838,796
ZIA · FY2024 · CA · contact PI
Mechanism of epigenetic activation during disease progression$828,107
ZIA · FY2023 · CA · contact PI
Identification of epigenetic drivers of advanced prostate cancer$828,107
ZIA · FY2023 · CA · contact PI
Mechanism of epigenetic activation during disease progression$810,824
ZIA · FY2022 · CA · contact PI
Identification of epigenetic drivers of advanced prostate cancer$810,824
ZIA · FY2022 · CA · contact PI
Identification of epigenetic drivers of advanced prostate cancer$650,607
ZIA · FY2021 · CA · contact PI
Mechanism of epigenetic activation during disease progression$650,607
ZIA · FY2021 · CA · contact PI
Mechanism of epigenetic activation during disease progression$770,014
ZIA · FY2020 · CA · contact PI
Identification of epigenetic drivers of castration-resistant prostate cancer$770,014
ZIA · FY2020 · CA · contact PI